Literature DB >> 21173170

Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Rachel L Winer1, James P Hughes, Qinghua Feng, Long Fu Xi, Stephen Cherne, Sandra O'Reilly, Nancy B Kiviat, Laura A Koutsky.   

Abstract

BACKGROUND: Characterizing short-term detection patterns of young women's incident α-genus human papillomavirus (HPV) infections may further our understanding of HPV transmission.
METHODS: Between 2000 and 2007, we followed 18- to 22-year-old female university students with triannual HPV DNA and Papanicolaou testing. Using Kaplan-Meier methods, we estimated duration of detectable, type-specific incident infections; time to redetection (among infections that became undetectable); and time to cervical lesion development after incident infection. We evaluated risk factors for short-term persistent versus transient infection with logistic regression.
RESULTS: Three hundred three incident, type-specific infections were detected in 85 sexually active women. Median time to first negative test after incident infection was 9.4 (95% CI: 7.8-11.2) months; 90.6% of infections became undetectable within 2 years. About 19.4% of infections that became undetectable were redetected within 1 year. Cervical lesions were common and 60% were positive for multiple HPV types in concurrent cervical swabs. Incident HPV detection in the cervix only (vs. the vulva/vagina only or both sites) was associated with short-term transience.
CONCLUSIONS: Although most incident infections became undetectable within 2 years, redetection was common. Cervical lesions were a common early manifestation of HPV infection. IMPACT: It remains unclear whether potentially modifiable risk factors can be identified to reduce infection duration (and transmission likelihood).

Entities:  

Mesh:

Year:  2010        PMID: 21173170      PMCID: PMC3078690          DOI: 10.1158/1055-9965.EPI-10-1108

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  20 in total

1.  Condom use and the risk of genital human papillomavirus infection in young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Sandra O'Reilly; Nancy B Kiviat; King K Holmes; Laura A Koutsky
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

2.  Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

Authors:  R J Kurman; D E Henson; A L Herbst; K L Noller; M H Schiffman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

3.  Development and duration of human papillomavirus lesions, after initial infection.

Authors:  Rachel L Winer; Nancy B Kiviat; James P Hughes; Diane E Adam; Shu-Kuang Lee; Jane M Kuypers; Laura A Koutsky
Journal:  J Infect Dis       Date:  2005-01-21       Impact factor: 5.226

4.  Natural history of cervicovaginal papillomavirus infection in young women.

Authors:  G Y Ho; R Bierman; L Beardsley; C J Chang; R D Burk
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

5.  Age-related changes of the cervix influence human papillomavirus type distribution.

Authors:  Philip E Castle; Jose Jeronimo; Mark Schiffman; Rolando Herrero; Ana C Rodríguez; M Concepción Bratti; Allan Hildesheim; Sholom Wacholder; L Rodney Long; Leif Neve; Ruth Pfeiffer; Robert D Burk
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  A population-based study of vaginal human papillomavirus infection in hysterectomized women.

Authors:  Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Rolando Herrero; Martha L Hutchinson; Ana Cecilia Rodriguez; Sholom Wacholder; Mark E Sherman; Hortense Kendall; Raphael P Viscidi; Jose Jeronimo; John E Schussler; Robert D Burk
Journal:  J Infect Dis       Date:  2004-07-02       Impact factor: 5.226

7.  Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.

Authors:  Rachel L Winer; Shu-Kuang Lee; James P Hughes; Diane E Adam; Nancy B Kiviat; Laura A Koutsky
Journal:  Am J Epidemiol       Date:  2003-02-01       Impact factor: 4.897

Review 8.  The geographical and temporal evolution of sexually transmitted disease epidemics.

Authors:  G P Garnett
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

9.  Determinants of persistent detection of human papillomavirus DNA in the uterine cervix.

Authors:  J Brisson; I Bairati; C Morin; M Fortier; C Bouchard; A Christen; P Bernard; M Roy; A Meisels
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

10.  Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.

Authors:  Nicolas Wentzensen; Mark Schiffman; Terence Dunn; Rosemary E Zuna; Michael A Gold; Richard A Allen; Roy Zhang; Mark E Sherman; Sholom Wacholder; Joan Walker; Sophia S Wang
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

View more
  42 in total

1.  Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.

Authors:  Tsung-chieh Jane Fu; Long Fu Xi; Ayaka Hulbert; James P Hughes; Qinghua Feng; Stephen M Schwartz; Stephen E Hawes; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

Review 2.  Addressing HPV vaccine myths: practical information for healthcare providers.

Authors:  Robert A Bednarczyk
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

3.  Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.

Authors:  Gabriele Galliverti; Stephan Wullschleger; Mélanie Tichet; Dhaarini Murugan; Nadine Zangger; Wesley Horton; Alan J Korman; Lisa M Coussens; Melody A Swartz; Douglas Hanahan
Journal:  Cancer Immunol Res       Date:  2019-11-26       Impact factor: 11.151

4.  Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillén; Mario Alfaro; Jorge Morales; Martha Hutchinson; Li Cheung; Sholom Wacholder; Robert D Burk
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

5.  Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.

Authors:  Diane M Da Silva; Carly A Movius; Adam B Raff; Heike E Brand; Joseph G Skeate; Michael K Wong; W Martin Kast
Journal:  Virology       Date:  2014-02-17       Impact factor: 3.616

6.  High frequency of human papillomavirus detection in the vagina before first vaginal intercourse among females enrolled in a longitudinal cohort study.

Authors:  Marcia L Shew; Bree Weaver; Wanzhu Tu; Yan Tong; J Dennis Fortenberry; Darron R Brown
Journal:  J Infect Dis       Date:  2012-12-13       Impact factor: 5.226

7.  Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.

Authors:  Lisa Beth Spiryda; Kara M Whitaker; Amy Messersmith; Carolyn E Banister; Kim E Creek; Lucia A Pirisi-Creek
Journal:  J Low Genit Tract Dis       Date:  2016-01       Impact factor: 1.925

8.  Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Sepideh Farhat; Teresa M Darragh; Michael Pawlita; Denise A Galloway; Stephen Shiboski
Journal:  J Infect Dis       Date:  2013-04-18       Impact factor: 5.226

9.  Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.

Authors:  Yan Tong; Aaron Ermel; Wanzhu Tu; Marcia Shew; Darron R Brown
Journal:  J Med Virol       Date:  2013-07-16       Impact factor: 2.327

10.  Human Papillomavirus (HPV) Infections and the Importance of HPV Vaccination.

Authors:  Chia-Ching J Wang; Joel M Palefsky
Journal:  Curr Epidemiol Rep       Date:  2015-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.